96 related articles for article (PubMed ID: 35091547)
1. The rational design of specific peptide inhibitor against p38α MAPK at allosteric-site: a therapeutic modality for HNSCC.
Gill K; Nigam L; Singh R; Kumar S; Subbarao N; Chauhan SS; Dey S
PLoS One; 2014; 9(7):e101525. PubMed ID: 24983631
[TBL] [Abstract][Full Text] [Related]
2. Energetics of displacing water molecules from protein binding sites: consequences for ligand optimization.
Michel J; Tirado-Rives J; Jorgensen WL
J Am Chem Soc; 2009 Oct; 131(42):15403-11. PubMed ID: 19778066
[TBL] [Abstract][Full Text] [Related]
3. Structure-affinity and structure-residence time relationships of macrocyclic Gα
Voss JH; Crüsemann M; Bartling CRO; Kehraus S; Inoue A; König GM; Strømgaard K; Müller CE
iScience; 2023 Apr; 26(4):106492. PubMed ID: 37091255
[TBL] [Abstract][Full Text] [Related]
4. M1 Macrophages Increase Endothelial Permeability and Enhance p38 Phosphorylation via PPAR-γ/CXCL13-CXCR5 in Sepsis.
Chen W; Wang Y; Zhou Y; Xu Y; Bo X; Wu J
Int Arch Allergy Immunol; 2022; 183(9):997-1006. PubMed ID: 35526523
[TBL] [Abstract][Full Text] [Related]
5. Surface Plasmon Resonance Biosensors: A Review of Molecular Imaging with High Spatial Resolution.
Xu J; Zhang P; Chen Y
Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392003
[TBL] [Abstract][Full Text] [Related]
6. Allo-targeting of the kinase domain: Insights from in silico studies and comparison with experiments.
Lee JY; Gebauer E; Seeliger MA; Bahar I
Curr Opin Struct Biol; 2024 Feb; 84():102770. PubMed ID: 38211377
[TBL] [Abstract][Full Text] [Related]
7. Markov State Models: To Optimize or Not to Optimize.
Arbon RE; Zhu Y; Mey ASJS
J Chem Theory Comput; 2024 Jan; 20(2):977-988. PubMed ID: 38163961
[TBL] [Abstract][Full Text] [Related]
8. Molecular Drug Simulation and Experimental Validation of the CD36 Receptor Competitively Binding to Long-Chain Fatty Acids by 7-Ketocholesteryl-9-carboxynonanoate.
Fu C; Xiang ML; Chen S; Dong G; Liu Z; Chen CB; Liang J; Cao Y; Zhang M; Liu Q
ACS Omega; 2023 Aug; 8(31):28277-28289. PubMed ID: 37576668
[TBL] [Abstract][Full Text] [Related]
9. Drug Design in the Exascale Era: A Perspective from Massively Parallel QM/MM Simulations.
Raghavan B; Paulikat M; Ahmad K; Callea L; Rizzi A; Ippoliti E; Mandelli D; Bonati L; De Vivo M; Carloni P
J Chem Inf Model; 2023 Jun; 63(12):3647-3658. PubMed ID: 37319347
[TBL] [Abstract][Full Text] [Related]
10. Structure-Kinetic Relationship for Drug Design Revealed by a PLS Model with Retrosynthesis-Based Pre-Trained Molecular Representation and Molecular Dynamics Simulation.
Zhou F; Yin S; Xiao Y; Lin Z; Fu W; Zhang YJ
ACS Omega; 2023 May; 8(20):18312-18322. PubMed ID: 37251166
[TBL] [Abstract][Full Text] [Related]
11. Long-Timescale Simulations Revealed Critical Non-Conserved Residues of Phosphodiesterases Affecting Selectivity of BAY60-7550.
Liu Q; Song M; Qiu Y; Lai-Han Leung E; Huang Q; Yao X
Comput Struct Biotechnol J; 2022; 20():5136-5149. PubMed ID: 36187927
[TBL] [Abstract][Full Text] [Related]
12. Water as the often neglected medium at the interface between materials and biology.
Dargaville BL; Hutmacher DW
Nat Commun; 2022 Jul; 13(1):4222. PubMed ID: 35864087
[TBL] [Abstract][Full Text] [Related]
13. Resemblance-Ranking Peptide Library to Screen for Binders to Antibodies on a Peptidomic Scale.
Jenne F; Biniaminov S; Biniaminov N; Marquardt P; von Bojničić-Kninski C; Popov R; Seckinger A; Hose D; Nesterov-Mueller A
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408876
[TBL] [Abstract][Full Text] [Related]
14. Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitors.
Pantsar T; Kaiser PD; Kudolo M; Forster M; Rothbauer U; Laufer SA
Nat Commun; 2022 Jan; 13(1):569. PubMed ID: 35091547
[TBL] [Abstract][Full Text] [Related]
15. Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.
Muth F; Günther M; Bauer SM; Döring E; Fischer S; Maier J; Drückes P; Köppler J; Trappe J; Rothbauer U; Koch P; Laufer SA
J Med Chem; 2015 Jan; 58(1):443-56. PubMed ID: 25475894
[TBL] [Abstract][Full Text] [Related]
16. Contributions of water transfer energy to protein-ligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors.
Pearlstein RA; Sherman W; Abel R
Proteins; 2013 Sep; 81(9):1509-26. PubMed ID: 23468227
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulation and free energy calculation studies of the binding mechanism of allosteric inhibitors with p38α MAP kinase.
Yang Y; Shen Y; Liu H; Yao X
J Chem Inf Model; 2011 Dec; 51(12):3235-46. PubMed ID: 22097958
[TBL] [Abstract][Full Text] [Related]
18. MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein.
Lee MR; Dominguez C
Curr Med Chem; 2005; 12(25):2979-94. PubMed ID: 16378500
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Structural Overview of p38α MAPK in Complex with Type I Inhibitors.
Astolfi A; Iraci N; Manfroni G; Barreca ML; Cecchetti V
ChemMedChem; 2015 Jun; 10(6):957-69. PubMed ID: 26012502
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
